Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential


Valirx Share Chat (VAL)



Share Price: 0.235Bid: 0.22Ask: 0.25Change: 0.02 (+9.30%)Riser - Valirx
Spread: 0.03Spread as %: 13.64%Open: 0.215High: 0.24Low: 0.215Yesterday’s Close: 0.215


Share Discussion for Valirx




View all VAL Messages

Please login or register to post a message on Share Chat.

Posts per page:

CHELSEA7
Posts: 36,309
Premium Chat Member
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Adam, a very fair post............""".Why would anybody have faith in this?""".....................and that is why I asked Uncanny the question. There are many variable that help calculate whether a share is fairly priced.

Do VAL have enough funds avaiable to progress trials to a point where the data is compelling?? Or indeed the will to do so.??

Is there any inflection based news to come in the short term to impact on the M/Cap??

Indeed what plans do the BOD have to increase the IP, and appeal to investors to back them in further clinical trials??

Why at this level do the BOD not increase any holdings they have to have more skin in the game?? That in itself is a worthy inflection point/

Uncanny your answer to my post was...........

"""What £2.5mn mkt cap compared to £16.5mn and £18.5mn of our closest peers?

Seems pretty obvious to me?!"""

Well, I wish you all goodnight on that one, Uncanny the best comment I can make on that is to say nothing., ....even I can understand why the market has valued Scancell at where it has, if you ever read that BB there are many reasons why investors can be hopeful of a very good return, there are also a few very good reasons why it jut might continue to fall.

As Adam just posted....................

""science can be amazing and the business can still fail."""

I don"t know anyboy on that BB who doesn"t consider that, it is only by considering different points of view, and the content of RNSs that we can best decide on that. And lets be fair if we did rely on RNS content, have the RNSs released by VAL for some time now, fairly refleted their value??

Night guys, another week.
 
AdamH90
Posts: 1,390
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Isn’t it obvious? Honestly, some of you lot need help! People need to buy some shares for this for it to be worth anywhere near that. They won’t because there is a very high chance that the lights will go out within months of them doing so. Also, the BOD are the least trustworthy on the entire market. Why would anybody have faith in this? The science can be amazing and the business can still fail.
Uncanny
Posts: 2,063
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
What £2.5mn mkt cap compared to £16.5mn and £18.5mn of our closest peers?

Seems pretty obvious to me?!
roses
Posts: 5,047
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Uncanny - we all know that math is your strong point, and you have just proved it once again.

If you can't add up, then don't or ask for some help.
Uncanny
Posts: 2,063
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Roses your rollox is also laughable so the 1 for 25 and 1 for 125 would mean the share price today would be 11p which is completely irrelevant now.

Why back track, why not stick to NOW.

£2.5mn mkt cap and 894mn shares in issue.

Our two closest peers are £16.5 and £18.7mn which is equivalent to 1.9 and 2.1p per share which makes VAL on better progressed IP 7 and 8 times undervalued.
Bankfool
Posts: 260
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Wow guess if you were subject to both consolidations your shares must be worth as close to £0 as to make no odds.
ratcliffewriter
Posts: 8,704
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
On that basis if you divide the sp by 125 and then by 25 you get 0.000096p. Uncanny you need to do some research, not soapbox rhetoric. So very glad I didn't pile in on your and others' exhortations over the last few months.
ratcliffewriter
Posts: 8,704
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
...Which would, I think, make each share worth .00263p. No wonder some folk are sitting on unrecoverable losses. But maybe not if your name begins with 'G' or 'S.'
roses
Posts: 5,047
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Sorry, 1 for 25. And 1 for 125

But the calculation is still right
roses
Posts: 5,047
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
I can’t be bothered working it out at the moment but I’m sure someone will.

We have had two consolidations so far, the first was 25 shares for one and then next was 125 new shares foe each old one.

So to work out how many shares we really have in circulation without the share number hocus pocus just multiply our current shares in issue by 25 and then multiply that by 125
roses
Posts: 5,047
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Sorry, that should read ‘. Over 100 BILLION shares in issue at the moment’
roses
Posts: 5,047
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Uncanny - yet again you have shown complete lack of understanding of share consolidations and their effect on shares in issue.

Valirx have consolidated twice now and at this rate will be doing it again quite soon.

They were forced to consolidate as the shareprice fell below 0.1p and as it was below the nominal value of the shares, they were legally restricted from doing any more placings (it was either consolidate or go bankrupt )

If val had not consolidated then there would be over 10 billion shares in issue at the moment.

Seriously if you don’t understand something then don’t comment on it or ask for help.
Uncanny
Posts: 2,063
Opinion:No Opinion
Price:0.35
RE: Sorry
19 May '19
Well done Drac, just shows you the difference in sentiment with SAR as compared to VAL at present.

SAR More than 3 times as many shares in issue to VAL, VAL have a P2 compound finished and moving in to P3, SAR are twice our SP????

VAL are more advanced, less shares in issue but 1/8 of the valuation.

Must be a massive rerate soon and maybe the catalyst is the next RNS’s on the updates. Also as 71mn shares issues to ABO, we’re not sure about the selling last week as the majority at .37 was buying, .35 sells of course but ABO are not dumping which to me suggests they are hanging around for newsflow.

AIMHO and GLA all genuine shareholders.
Dracula1
Posts: 971
Opinion:No Opinion
Price:0.35
Sorry
19 May '19
I had It all In line.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk







Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.